淼淼Elva

Paper Talk

Sharing research articles, tracking the latest developments

Besuch unbedingt die Website des Podcasts und unterstütze die Macher: www.xiaoyuzhoufm.com

Autor

淼淼Elva

Kategorie

Science

Podcast-Website

www.xiaoyuzhoufm.com

Neueste Folge

20. Okt 2026

Wo hören?

Podcasts in der App Replaio Radio Bald verfügbar

Podcasts kommen bald in die App. Installiere sie jetzt und erlebe als Erster einen ganz neuen Blick auf Podcasts

Bei Google Play herunterladen Kostenlos installieren Android fast 10 Mio. Downloads · Bewertung 4,8 iOS bald

Folgen

1143-Spatial Heterogeneity of Triple-Negative Breast Cancer 17.06.2026

This study utilizes spatial transcriptomics to analyze the complex internal structure and microenvironment of triple-negative breast cancer (TNBC). By examining 92 patients, researchers identified that traditional molecular classifications often overlook significant intratumoral heterogeneity and the critical role of the stroma in disease progression. A major finding is the development of a 30-gen...

1142-Spatial Cell Interactions in HER2+ Breast Cancer 17.06.2026

This study utilizes Spatial Transcriptomics (ST) to investigate the complex cellular landscapes of HER2-positive breast cancer across 36 tissue sections. By integrating spatial gene expression with single-cell data, researchers identified distinct molecular signatures and mapped the precise locations of various immune and tumor cell types. A significant discovery includes a type I interferon respo...

1141-HBV HBx Protein Subversion of Host Epigenetic Control 17.06.2026

The paper outlines a structural study of the HBx protein, an essential regulatory component of the Hepatitis B virus linked to the development of liver cancer. Using NMR spectroscopy and AlphaFold predictions, researchers discovered that the HBx1–120 isoform is naturally disordered but folds locally when it hijacks human host proteins like Bcl-xL and Spindlin1. The study specifically identifies a...

1140-Evaluating Feature Reduction Methods for Drug model 16.06.2026

This study evaluates various feature reduction (FR) techniques to enhance drug response prediction (DRP) using machine learning on high-dimensional molecular data. Researchers compared nine knowledge-based and data-driven methods across thousands of tests involving cancer cell lines and human tumor samples. While techniques like sparse principal components and Landmark genes performed well on cell...

1139-Interpretable Drug Synergy Prediction 16.06.2026

This research presents an interpretable machine learning framework designed to predict drug combination synergy in breast cancer treatment. Researchers developed a random forest model that utilizes simulated protein activities, generated through Boolean modeling of signaling pathways, as its primary input features. Unlike "black box" models, this approach allows for local interpretability, meaning...

1138-SiamCDR: for Enhanced Anti-Cancer Drug Prioritization 16.06.2026

The researchers introduce SiamCDR, a novel computational framework designed to improve the prediction of how specific cancer cell lines respond to various drugs. By utilizing contrastive learning and Siamese neural networks, the model creates highly expressive digital representations that group drugs by their molecular mechanisms and cell lines by their cancer types. The study demonstrates that Si...

1137-CTDPathSim2.0: Mapping of Cell Lines to Patient Tumors 16.06.2026

This study introduces CTDPathSim2.0, a computational framework designed to identify which laboratory cell lines most accurately represent individual patient tumors. Researchers developed this tool because cell lines often undergo genetic changes in vitro, causing them to deviate from the biology of actual human cancers. By integrating multi-omics data—including gene expression, DNA methylation, an...

1136-Deep Learning Architectures for Drug Synergy Prediction 16.06.2026

This review explores the evolution and application of deep learning for predicting anti-cancer drug synergy, a therapeutic approach that improves efficacy while minimizing side effects. It categorizes computational models into single-task and multi-task learning frameworks, detailing how they utilize biomedical data such as chemical structures and genomic profiles. The authors highlight various be...

1135-Drug Response Models for Personalised Cancer Therapy 15.06.2026

Researchers have developed a machine learning methodology to predict how individual cancer patients will respond to various medications by using functional drug screening rather than relying solely on genetic data. By testing a small panel of "probing" drugs on patient-derived cell cultures, the system analyzes historical data from other cell lines to accurately forecast the effectiveness of a muc...

1134-Reliable Drug Sensitivity Prediction and Prioritization 15.06.2026

This research introduces a machine learning framework designed to improve the reliability and prioritization of anti-cancer drug treatments. Central to this approach is the use of conformal prediction, a mathematical method that provides certainty guarantees for drug sensitivity results rather than simple point estimates. To enhance clinical relevance, the authors developed CMax viability, a novel...

1133-MutliSyn: for Drug Combination Synergy Prediction 15.06.2026

The research introduces MutliSyn, a sophisticated multi-task deep learning framework designed to predict the synergistic effectiveness of combining different drugs to treat cancer. By simultaneously calculating synergy scores and identifying classification labels, the model determines whether drug pairings will enhance therapeutic results while reducing toxic side effects. The architecture integra...

1132-Astrocytic Sodium Homeostasis in Mouse Brain 15.06.2026

This research article details the discovery of significant cellular and subcellular sodium heterogeneity within mouse brain astrocytes. Using advanced multi-photon fluorescence lifetime imaging (MP-FLIM), the authors demonstrate that internal sodium levels are not uniform, as previously believed, but vary between the cell body and its processes. The data reveals a bimodal distribution of sodium co...

1131-Recurrent Multiplicity of TGFβ Domains in Vertebrates 15.06.2026

This study identifies a significant evolutionary shift in the TGFβ signaling pathway, a system previously thought to be highly conserved across all vertebrates. Researchers discovered 12 independent instances of ligand-binding domain (LBD) multiplication within three specific receptor classes: ACVR1, BMPR2, and TGFBR2. While most metazoans possess receptors with only a single LBD, diverse lineages...

1130-The Microbiota-SNHG9-MAS Axis in Liver Protection 14.06.2026

This research identifies a novel gut-liver axis where the long non-coding RNA SNHG9 protects against drug-induced liver injury (DILI), specifically from acetaminophen overdose. The study demonstrates that the gut microbiota modulates hepatic SNHG9 levels through the metabolite HMB, which is primarily produced by bacteria like Lactobacillus plantarum. Mechanistically, SNHG9 binds to the protein IMP...

1129-VEGFR2 Requirements in Lymphatic Sprouting 14.06.2026

This article demonstrates that VEGFR2 is an essential collaborator in the sprouting of lymphatic vessels, a process previously thought to be driven primarily by VEGFR3. Through genetic experiments in mice, researchers found that while VEGFR2 cannot trigger vessel growth on its own, its absence prevents lymphatic cells from forming new branches. The study explains that VEGF-C coordinates these two...

1128-DrEval: Evaluation of Drug Response Prediction Models 14.06.2026

This article introduces DrEval, an open-source benchmarking framework designed to address the reproducibility crisis and performance inflation in cancer drug response modeling. The authors identify critical flaws in current research, such as data leakage, biased evaluation metrics, and the failure of complex deep learning models to outperform simple tree-based baselines. By utilizing application-a...

1127-Dual Targeting Mechanisms of Tetracyclines 14.06.2026

Researchers have identified a dual-site mechanism of action for the tetracycline class of antibiotics, revealing that these drugs target both the mRNA decoding center and the nascent peptide exit tunnel (NPET) of the bacterial ribosome. Using high-resolution cryo-electron microscopy, the study demonstrates that while tetracyclines traditionally disrupt translation at the 30S subunit, they also bin...

1126-Key Microbial Allies for Coral Resilience 14.06.2026

This research explores how certain corals survive in highly polluted, nitrate-rich waters by associating with specialized microbial allies. While many denitrifying bacteria are common across all reefs, the authors identified unique, hyper-efficient populations within the genus Ruegeria that are specifically enriched in corals from eutrophic "reef oases." These specialists convert harmful nitrates...

1125-Multi-Modal Profiling of Antigen-Specific CD4+ T Cells 13.06.2026

This research introduces APMAT-CD4, a high-throughput platform designed to identify and characterize antigen-specific CD4+ T cells at single-cell resolution. The authors developed a modular system using class II single-chain trimer libraries to overcome the technical challenges of profiling helper T cells across multiple dimensions, including TCR sequences, transcriptomes, and MHC restriction. The...

1124-Pericytes Regulates Tissue Morphogenesis 13.06.2026

This research explores how pericytes, cells that support blood vessels, act as organ-specific signaling centers to guide tissue development. By using mouse genetics and single-cell RNA sequencing, the study demonstrates that pericytes release distinct paracrine factors depending on their location in the body. In the postnatal lung, pericyte-derived HGF and BDNF are essential for healthy growth, as...

1123-Carrageenan Catabolism in Ruminant Microbiomes 13.06.2026

This research investigates how ruminant livestock can digest seaweed polysaccharides, specifically carrageenan, through specialized microbial pathways. By analyzing the microbiomes of cattle fed red seaweed, scientists identified carrageenan-active polysaccharide utilization loci (CarPULs) within the genus Bacteroides. These genetic pathways, which encode keystone enzymes and sulfatases, allow the...

1122-Patient-Derived Xenograft Models in Cancer Therapy 13.06.2026

This paper is a comprehensive overview of Patient-derived xenograft (PDX) models, a sophisticated preclinical tool where human tumor tissues are transplanted into mice to study cancer therapy. Unlike traditional cell lines, PDX models accurately replicate intratumor heterogeneity, the complex spatial architecture of tumors, and the specific genomic features of individual patients. The text explain...

1121-Alternative Splicing in Cardiac Disease 13.06.2026

This research identifies a novel transcription start site for the cardiac splicing regulator RBM20, which produces a shorter but functional protein isoform conserved across humans, mice, and rats. While the canonical isoform usually predominates, this alternative isoform lacks the first exon yet retains the ability to regulate alternative splicing for essential heart proteins like titin. The study...

1120-eIF4G2 Buffering of Chromatin Regulators 12.06.2026

This research explains how the protein eIF4G2 acts as a vital safeguard for the identity and function of adult intestinal stem cells. By analyzing mice lacking this specific factor, researchers discovered that its absence causes the intestinal lining to lose its mature characteristics and revert to a fetal-like state. This cellular transformation occurs because eIF4G2 is required to translate key...

1119-Regenerative Skin Remodeling in Systemic Sclerosis 12.06.2026

This research examines the transformative effects of CD19-CAR T cell therapy on patients with systemic sclerosis (SSc), a severe autoimmune disease marked by debilitating skin fibrosis and vascular damage. Utilizing advanced deep phenotyping techniques like spatial transcriptomics (cISH) and imaging mass cytometry (IMC), the study demonstrates that the treatment can actually regenerate complex ski...

Höre den Podcast Paper Talk in Replaio

Radio und Podcasts in einer App - kostenlos und ohne Anmeldung. Installiere sie noch heute und verpasse den Start nicht

Bei Google Play herunterladen

Replaio ist kein Herausgeber von Podcasts; die Namen der Sendungen, Cover und Audioinhalte gehören ihren Autoren und werden über öffentliche RSS-Feeds verbreitet